Clinical trial
Cardiovascular Risk in Growth Hormone Deficient Young Adult Males After Completing Growth Hormone Therapy.
NCT00711061 is registered in ClinicalTrials.gov with Children's Mercy Hospital Kansas City as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cardiovascular Risk in Growth Hormone Deficient Young Adult Males After Completing Growth Hormone Therapy.
- Lead sponsor
- Children's Mercy Hospital Kansas City
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2008
- Completion date
- February 28, 2009
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
growth hormone deficiency